Oviva Therapeutics
Latest round
- Seed
Last raised
- May 2022
Total raised
- $12M
Investors
- 1
About Oviva Therapeutics
Founded in 2021 and based in New York, US, Oviva Therapeutics, Inc. is a majority-owned pipeline company (PipeCo) of Cambrian Biopharma, a multi-asset longevity biotech company developing therapeutics to first cure diseases and then develop treatments to prevent conditions from occurring. In May 2022, Oviva Therapeutics, Inc. Daisy Robinton (CEO), David Pépin, and Patricia K. Donahoe are the co-founders of the company. The company is developing a drug that targets folliculogenesis, the process by which ovarian follicles, each containing a single egg, mature and eventually ovulate.
Who invested in Oviva Therapeutics
1 investor across 1 round
See all investors in Oviva Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 19, 2022
Amount
$12M
Investors
Questions about Oviva Therapeutics
Who invested in Oviva Therapeutics?
Oviva Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oviva Therapeutics raised?
Oviva Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oviva Therapeutics last raise money?
Oviva Therapeutics's most recent round on record is a Seed, in May 2022.
What does Oviva Therapeutics do?
Founded in 2021 and based in New York, US, Oviva Therapeutics, Inc.
Where is Oviva Therapeutics headquartered?
Oviva Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Oviva Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oviva Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Oviva Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.